肝細胞によるプロコラーゲン1型生成:進行性肝疾患のマーカー?
G Malizia1, G Giannuoli, M Caltagirone
1Divisione di Medicina, Ospedale V Cervello, Palermo, Italy.
Lancet (London, England)
|November 7, 1987
まとめ
肝臓疾患の肝細胞は,コラーゲンの前駆体であるプロコラーゲンI型を産生する. この発見は,進行性肝疾患のための新しいマーカーを示唆し,診断とモニタリングに役立ちます.
科学分野:
- 肝臓病理学 肝臓病理学
- 免疫ヒストキミストリー
- バイオケミストリー バイオケミストリー
背景:
- 慢性肝疾患は,コラーゲンの堆積を含むプロセスである線維症によって特徴付けられます.
- コラーゲンの細胞源を特定することは,疾患の進行を理解するために不可欠です.
研究 の 目的:
- 慢性肝疾患の様々な段階におけるコラーゲン生成細胞の存在と細胞の局所を調査する.
- コラーゲン産生と疾患活動との関係を決定する.
主な方法:
- プロコラーゲンI型 (アンチ-Pc) に対するモノクローナル抗体を用いた免疫光技術.
- 肝硬化症,非活性肝硬化症,慢性持続性肝炎,および正常な組織学的疾患を有する患者の肝臓組織の断片の分析.
主要な成果:
- プロコラーゲンI型に対する強い細胞内染色は,活発な肝硬変の患者の肝細胞で観察されました.
- 胆管は,いくつかの活発な肝硬変の症例でも膜のような反応を示した.
- 不活性の肝疾患と正常な肝臓からの組織断面は,プロコラーゲンI型に対して大部分ネガティブでした.
結論:
- 肝細胞と,場合によっては,胆道上皮質は,慢性肝疾患において,積極的にコラーゲンを産生する.
- コラーゲン生成は,肝疾患の活動と直接関係しています.
- 肝細胞におけるプロコラーゲンI型の検出は,進行性肝疾患の貴重なバイオマーカーとして機能する可能性があります.
関連する概念動画
Type IV Collagen of Basal Lamina
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
A type IV collagen molecule has six alpha chains which can exist in...
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


